Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

This study has been completed.
Sponsor:
Collaborator:
Department of Health, United Kingdom
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00159250
First received: September 8, 2005
Last updated: February 22, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
No publications provided by Imperial College London

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):